Series A momentum Junction recently announced an $18M Series A led by Creandum with participation from Y Combinator, Point Nine, Amino Collective, and Inflect Health, signaling strong investor confidence and potential for rapid expansion, partnerships, and co selling opportunities with portfolio companies.

Healthcare infrastructure Positioned as a healthcare infrastructure platform that unifies API connections to wearables, labs, and testing networks, Junction presents cross selling potential to digital health startups, clinics, labs, and hospital systems seeking to scale data integrations and streamline operations.

Operational efficiency With capabilities spanning test ordering, results retrieval, 5000+ walk in centers, home lab kits, and mobile phlebotomy scheduling, Junction can be pitched to healthcare providers and networks aiming to reduce administrative burden and accelerate patient workflows.

Multi state reach Support for personalized care using wearables and cost effective specialty lab testing across 50 states offers a strong selling point to national providers, telehealth platforms, and multi site health systems seeking scalable data pipelines.

Data driven growth Core tech stack and analytics capabilities (BigQuery, PostgreSQL, HubSpot, Jira) enable selling points around robust data insights, secure data ecosystems, and seamless integration into existing tech stacks for improved clinical trial recruitment, outcomes tracking, and decision support.